These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24357461)

  • 21. Myeloid-related protein 8 induces self-tolerance and cross-tolerance to bacterial infection via TLR4- and TLR2-mediated signal pathways.
    Coveney AP; Wang W; Kelly J; Liu JH; Blankson S; Wu QD; Redmond HP; Wang JH
    Sci Rep; 2015 Sep; 5():13694. PubMed ID: 26329314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Inhibitory Effect of Rapamycin on Toll Like Receptor 4 and Interleukin 17 in the Early Stage of Rat Diabetic Nephropathy.
    Yu R; Bo H; Villani V; Spencer PJ; Fu P
    Kidney Blood Press Res; 2016; 41(1):55-69. PubMed ID: 26849067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
    Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
    Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of LPS on the level of TLR4 and on the expression of NF-κB and Notch1 in monocytes from patients with type 2 diabetic nephropathy].
    Yang M; Gan H; Shen Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 37(6):578-85. PubMed ID: 22772413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tim-3 aggravates podocyte injury in diabetic nephropathy by promoting macrophage activation via the NF-κB/TNF-α pathway.
    Yang H; Xie T; Li D; Du X; Wang T; Li C; Song X; Xu L; Yi F; Liang X; Gao L; Yang X; Ma C
    Mol Metab; 2019 May; 23():24-36. PubMed ID: 30862474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dioscin protects against diabetic nephropathy by inhibiting renal inflammation through TLR4/NF-κB pathway in mice.
    Cai S; Chen J; Li Y
    Immunobiology; 2020 May; 225(3):151941. PubMed ID: 32359778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a CCR2 antagonist on macrophages and Toll-like receptor 9 expression in a mouse model of diabetic nephropathy.
    Ito S; Nakashima H; Ishikiriyama T; Nakashima M; Yamagata A; Imakiire T; Kinoshita M; Seki S; Kumagai H; Oshima N
    Am J Physiol Renal Physiol; 2021 Dec; 321(6):F757-F770. PubMed ID: 34719947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyperglycemia induces Toll like receptor 4 expression and activity in mouse mesangial cells: relevance to diabetic nephropathy.
    Kaur H; Chien A; Jialal I
    Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1145-50. PubMed ID: 22874765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of Angiopoietin-Like Protein 2 Ameliorates Diabetic Nephropathy by Inhibiting TLR4.
    Yang S; Zhang J; Wang S; Shi J; Zhao X
    Cell Physiol Biochem; 2017; 43(2):685-696. PubMed ID: 28946139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant fibrous histiocytoma amplified sequence 1 alleviates inflammation and renal fibrosis in diabetic nephropathy by inhibiting TLR4.
    Lian H; Cheng Y; Wu X
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31696221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toll-Like Receptor 4 Activation Contributes to Diabetic Bladder Dysfunction in a Murine Model of Type 1 Diabetes.
    Szasz T; Wenceslau CF; Burgess B; Nunes KP; Webb RC
    Diabetes; 2016 Dec; 65(12):3754-3764. PubMed ID: 27650857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MRP8/14 mediates macrophage efferocytosis through RAGE and Gas6/MFG-E8, and induces polarization via TLR4-dependent pathway.
    Li K; Chen G; Luo H; Li J; Liu A; Yang C; Wang J; Xu J; Gao S; Chen P; Jiang Y
    J Cell Physiol; 2021 Feb; 236(2):1375-1390. PubMed ID: 33128793
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin prevents diabetic nephropathy against inflammatory response via reversing caveolin-1 Tyr14 phosphorylation influenced TLR4 activation.
    Sun LN; Yang ZY; Lv SS; Liu XC; Guan GJ; Liu G
    Int Immunopharmacol; 2014 Nov; 23(1):236-46. PubMed ID: 25196431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-κB pathway.
    Wang H; Huang X; Xu P; Liu X; Zhou Z; Wang F; Li J; Wang Y; Xian X; Liu G; Huang W
    Metabolism; 2021 Jun; 119():154740. PubMed ID: 33639183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signaling between pancreatic β cells and macrophages via S100 calcium-binding protein A8 exacerbates β-cell apoptosis and islet inflammation.
    Inoue H; Shirakawa J; Togashi Y; Tajima K; Okuyama T; Kyohara M; Tanaka Y; Orime K; Saisho Y; Yamada T; Shibue K; Kulkarni RN; Terauchi Y
    J Biol Chem; 2018 Apr; 293(16):5934-5946. PubMed ID: 29496993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock.
    Vogl T; Tenbrock K; Ludwig S; Leukert N; Ehrhardt C; van Zoelen MA; Nacken W; Foell D; van der Poll T; Sorg C; Roth J
    Nat Med; 2007 Sep; 13(9):1042-9. PubMed ID: 17767165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.
    Lu Z; Zhang X; Li Y; Lopes-Virella MF; Huang Y
    Immunobiology; 2015 Nov; 220(11):1246-54. PubMed ID: 26162692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TLR4 regulates cardiac lipid accumulation and diabetic heart disease in the nonobese diabetic mouse model of type 1 diabetes.
    Dong B; Qi D; Yang L; Huang Y; Xiao X; Tai N; Wen L; Wong FS
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(6):H732-42. PubMed ID: 22842069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of variants rs5030717 and rs5030718 of TLR4 in the risk prediction of nephropathy, hypertension and dyslipidaemia in type 2 diabetes mellitus.
    Abbas SA; Raza ST; Mir SS; Siddiqi Z; Zaidi A; Zaidi ZH; Mahdi F
    Br J Biomed Sci; 2018 Oct; 75(4):163-168. PubMed ID: 30211669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGF-1R Inhibitor Ameliorates Diabetic Nephropathy with Suppressed HMGN1/TLR4 Pathway.
    Yu J; Da J; Dong R; Sun Y; Nie Y; Yu F; Zuo L; Zha Y
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):241-250. PubMed ID: 29384065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.